Literature DB >> 11161453

The expression and potential function of cellular prion protein in human lymphocytes.

R Li1, D Liu, G Zanusso, T Liu, J D Fayen, J H Huang, R B Petersen, P Gambetti, M S Sy.   

Abstract

We examined expression of the normal cellular prion protein (PrP(C)) in human peripheral blood mononuclear cells (PBMC) and in transfected neuroblastoma cells with a panel of six monoclonal antibodies (Mabs). While all six of the Mabs reacted strongly with the neuroblastoma cells, only four of the Mabs reacted with PrP(C) expressed by human PBMC. PrP(C) is expressed at high levels in human T cells, B cells, monocytes, and dendritic cells, but not in red blood cells. Immunoblotting studies revealed that the PrP(C) glycoforms and the composition of the N-linked glycans on PrP(C) in human PBMC are different from those of the brain or the neuroblastoma cells. In human PBMC and the neuroblastoma cell lines the N-terminal portion of the PrP(C) is hypersensitive to proteolytic digestion, suggesting that the N-terminus of the PrP(C) on the surface of a living cell lacks secondary structure. We found that the level of PrP(C) expressed on the surface of human T lymphocytes was up-regulated as a consequence of cellular activation. Accordingly, memory T cells express more PrP(C) than naïve T cells. In addition, the proliferation of human T lymphocytes stimulated with an anti-CD3 Mab was inhibited by anti-PrP(C) Mabs. Collectively, these results suggest that PrP(C) can participate in signal transduction in human T lymphocytes. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161453     DOI: 10.1006/cimm.2000.1751

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  25 in total

Review 1.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

2.  Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation.

Authors:  Tzu-Hao Wang; Angel Chao; Chia-Lung Tsai; Chih-Long Chang; Shun-Hua Chen; Yun-Shien Lee; Jen-Kun Chen; Yi-Jun Lin; Pi-Yueh Chang; Chin-Jung Wang; An-Shine Chao; Shuenn-Dyh Chang; Ting-Chang Chang; Chyong-Huey Lai; Hsin-Shih Wang
Journal:  Mol Cell Proteomics       Date:  2010-05-25       Impact factor: 5.911

3.  Oral scrapie infection modifies the homeostasis of Peyer's patches' dendritic cells.

Authors:  Gauthier Dorban; Valérie Defaweux; Etienne Levavasseur; Caroline Demonceau; Olivier Thellin; Sylvain Flandroy; Joëlle Piret; Nandini Falisse; Ernst Heinen; Nadine Antoine
Journal:  Histochem Cell Biol       Date:  2007-07-11       Impact factor: 4.304

4.  Normal cellular prion protein is a ligand of selectins: binding requires Le(X) but is inhibited by sLe(X).

Authors:  Chaoyang Li; Poki Wong; Tao Pan; Fan Xiao; Shaoman Yin; Binggong Chang; Shin-Chung Kang; James Ironside; Man-Sun Sy
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

5.  Ablation of the cellular prion protein, PrPC, specifically on follicular dendritic cells has no effect on their maturation or function.

Authors:  Laura McCulloch; Karen L Brown; Neil A Mabbott
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

6.  Association of cellular prion protein with gangliosides in plasma membrane microdomains of neural and lymphocytic cells.

Authors:  Vincenzo Mattei; Tina Garofalo; Roberta Misasi; Chiara Gizzi; Maria Teresa Mascellino; Vincenza Dolo; Giuseppe M Pontieri; Maurizio Sorice; Antonio Pavan
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

7.  Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis.

Authors:  Shigeki Tsutsui; Jennifer N Hahn; Trina A Johnson; Zenobia Ali; Frank R Jirik
Journal:  Am J Pathol       Date:  2008-10       Impact factor: 4.307

8.  Perturbation of T-cell development by insertional mutation of a PrP transgene.

Authors:  Mark Zabel; Christina Greenwood; Alana M Thackray; Bruce Pulford; Willem Rens; Raymond Bujdoso
Journal:  Immunology       Date:  2008-10-21       Impact factor: 7.397

9.  Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling.

Authors:  Wei Hu; Stefan Nessler; Bernhard Hemmer; Todd N Eagar; Lawrence P Kane; S Rutger Leliveld; Andreas Müller-Schiffmann; Anne R Gocke; Amy Lovett-Racke; Li-Hong Ben; Rehana Z Hussain; Andreas Breil; Jeffrey L Elliott; Krishna Puttaparthi; Petra D Cravens; Mahendra P Singh; Benjamin Petsch; Lothar Stitz; Michael K Racke; Carsten Korth; Olaf Stüve
Journal:  Brain       Date:  2010-02-09       Impact factor: 13.501

10.  The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cells.

Authors:  Jeremy D Isaacs; Oliver A Garden; Gurman Kaur; John Collinge; Graham S Jackson; Daniel M Altmann
Journal:  Immunology       Date:  2008-05-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.